|Mnemonic: ||[AFP TM]|
|Name: ||Alpha Fetoprotein (AFP), Non Pregnancy (Tumor Marker)|
|Specimen: ||1 mL serum from a Red SST or Red top tube. Hemolyzed samples are not acceptable. Plasma or body fluid samples are not acceptable.|
Grossly hemolyzed samples are unacceptable.
Separate serum samples from the cells within 4 hours of collection.
|Minimum Spec: ||0.2 mL|
|Transport Temp: ||Refrigerated|
|Spec Stability: ||Stable 7 days refrigerated.|
|Ref Lab/Code: ||ARUP 0080428|
| Method: ||Chemiluminescent Immunoassay|
|Note: ||Interpretive Data: The Beckman Coulter Access DxI AFP method is used. Results obtained with different assay methods or kits cannot be used interchangeably. AFP is a valuable aid in the management of nonseminomatous testicular cancer patients when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. Increased AFP concentrations have also been observed in ataxia telangiectasia, hereditary tyrosinemia, primary hepatocellular carcinoma, teratocarcinoma, gastrointestinal tract cancers with and without liver metastases, and in benign hepatic conditions such as acute viral hepatitis, chronic active hepatitis, and cirrhosis. The result cannot be interpreted as absolute evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females.|